Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]
2005 · BMC Cancer · 69 citations
https://doi.org/10.1186/1471-2407-5-131